David Twesigomwe to Humans
This is a "connection" page, showing publications David Twesigomwe has written about Humans.
Connection Strength
0,361
-
Characterization of NAT, GST, and CYP2E1 Genetic Variation in Sub-Saharan African Populations: Implications for Treatment of Tuberculosis and Other Diseases. Clin Pharmacol Ther. 2025 May; 117(5):1338-1357.
Score: 0,073
-
Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations. Clin Pharmacol Ther. 2024 03; 115(3):576-594.
Score: 0,068
-
Characterization of CYP2D6 Pharmacogenetic Variation in Sub-Saharan African Populations. Clin Pharmacol Ther. 2023 03; 113(3):643-659.
Score: 0,063
-
StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes. Clin Pharmacol Ther. 2021 09; 110(3):741-749.
Score: 0,056
-
High-coverage nanopore sequencing of samples from the 1000 Genomes Project to build a comprehensive catalog of human genetic variation. Genome Res. 2024 Nov 20; 34(11):2061-2073.
Score: 0,018
-
The variation landscape of CYP2D6 in a multi-ethnic Asian population. Sci Rep. 2024 07 20; 14(1):16725.
Score: 0,018
-
Characterization of CYP2C19 pharmacogenetic variation in African populations and comparison with other global populations. Pharmacogenomics. 2023 Nov; 24(16):845-857.
Score: 0,017
-
Characterizing the combined effects of cytochrome P450 missense variation within star allele definitions. Pharmacogenomics. 2023 07; 24(10):561-578.
Score: 0,017
-
Promoting Pharmacogenomics in Africa: Perspectives From Variation in G6PD and Other Pharmacogenes. Clin Pharmacol Ther. 2023 03; 113(3):476-479.
Score: 0,016
-
Characterization of POR haplotype distribution in African populations and comparison with other global populations. Pharmacogenomics. 2022 09; 23(14):771-782.
Score: 0,016